Drug · DIN 02270684
RAPAMUNE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 9, 2024.
- Drug Identification Number (DIN)
- 02270684
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sirolimus L04AH01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIROLIMUS | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 8, 2010: NOC 11800New Drug Submission (NDS) · Manufacturer name change
- August 29, 2005: NOC 7333Supplement to a New Drug Submission (SNDS) · New strength: 5 mg tablets
Other DINs named RAPAMUNE
- DIN 02243237 · Marketed
- DIN 02247111 · Marketed
- DIN 02270617 · Cancelled Pre Market